Zobrazeno 1 - 10 of 1 363 pro vyhledávání: '"Zoon KC"'
2
Akademický článek
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
Autor: Green DS; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland.; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, Maryland., Ning F; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Duemler A; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Myers TG; Genomic Technologies Section, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, Maryland., Trewhitt K; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Ekwede I; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., McCoy A; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Houston N; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Lee JM; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Lipkowitz S; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Zimmer A; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Pavelova M; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Villanueva EN; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Smith L; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Blakely A; Surgical Oncology Program, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Casablanca Y; Gynecologic Oncology, Walter Reed National Military Medical Center, Bethesda, Maryland., Highfill SL; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland., Stroncek DF; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland., Collins-Johnson N; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland., Panch S; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland., Procter J; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland., Pham C; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland., Korrapati S; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Holland SM; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland., Rosen LB; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland., Nunes AT; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Zoon KC; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, Maryland., Cole CB; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research (CCR), NCI, Bethesda, Maryland.
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jan 17; Vol. 29 (2), pp. 349-363.
Zobrazit plný text záznamu
3
Akademický článek
Novel peripheral blood mononuclear cell mRNA signature for IFN-beta therapy responsiveness prediction in multiple sclerosis.
Autor: Yang Xue1, Pengqi Yin2, Hongping Chen1, Guozhong Li3 hmu_guozhongli@126.com, Di Zhong1 dityanhmu@163.com
Publikováno v: Autoimmunity. Dec2024, Vol. 57 Issue 1, p1-12. 12p.
Zobrazit plný text záznamu
4
Akademický článek
The importance of IFNα2A (Roferon-A) in HSV-1 latency and T cell exhaustion in ocularly infected mice.
Autor: Wang, Shaohui1 (AUTHOR), Jaggi, Ujjaldeep1 (AUTHOR), Katsumata, Makoto2 (AUTHOR), Ghiasi, Homayon1 (AUTHOR) ghiasih@cshs.org
Publikováno v: PLoS Pathogens. 10/01/2024, Vol. 20 Issue 10, p1-24. 24p.
Zobrazit plný text záznamu
6
Akademický článek
A convenient broad-host counterselectable system endowing rapid genetic manipulations of Kluyveromyces lactis and other yeast species.
Autor: Zheng, Yanli1 (AUTHOR), Deng, Yuhui1 (AUTHOR), Hu, Ping1 (AUTHOR), Wang, Shiqing1 (AUTHOR), Wu, Jiawen1 (AUTHOR), Luo, Siqi1,2 (AUTHOR), Lei, Lei1 (AUTHOR), Yang, Jiangke1 (AUTHOR), Peng, Wenfang2 (AUTHOR) wenfang@hubu.edu.cn
Publikováno v: Microbial Cell Factories. 7/26/2024, Vol. 23 Issue 1, p1-9. 9p.
Zobrazit plný text záznamu
7
Akademický článek
Hainanenin-1, an oncolytic peptide, triggers immunogenic cell death via STING activation in triple-negative breast cancer.
Autor: Li, Xiaoxi1 (AUTHOR), Su, Nan1 (AUTHOR), Yu, Haining2 (AUTHOR) 576609286@qq.com, Li, Xiaoyan3 (AUTHOR) lixiaoyan@cancerhosp-ln-cmu.com, Sun, Shu-lan4 (AUTHOR) sunshulan@cancerhosp-ln-cmu.com
Publikováno v: Cell Communication & Signaling. 7/5/2024, Vol. 22 Issue 1, p1-16. 16p.
Zobrazit plný text záznamu
8
Akademický článek
Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancer.
Autor: Green DS; Cytokine Biology Section, Division of Intramural Research, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA.; Translational Genomics Section, Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA., Husain SR; Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Food & Drug Administration, Center for Biologics Evaluation & Research, Silver Spring, MD 20993, USA., Johnson CL; Cytokine Biology Section, Division of Intramural Research, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA., Sato Y; Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Food & Drug Administration, Center for Biologics Evaluation & Research, Silver Spring, MD 20993, USA., Han J; Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Food & Drug Administration, Center for Biologics Evaluation & Research, Silver Spring, MD 20993, USA., Joshi B; Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Food & Drug Administration, Center for Biologics Evaluation & Research, Silver Spring, MD 20993, USA., Hewitt SM; Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA., Puri RK; Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Food & Drug Administration, Center for Biologics Evaluation & Research, Silver Spring, MD 20993, USA., Zoon KC; Cytokine Biology Section, Division of Intramural Research, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA.; Laboratory of Infectious Diseases, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, 20814, USA.
Publikováno v: Immunotherapy [Immunotherapy] 2019 Apr; Vol. 11 (6), pp. 483-496.
Zobrazit plný text záznamu
9
Akademický článek
Production of a cellular product consisting of monocytes stimulated with Sylatron ® (Peginterferon alfa-2b) and Actimmune ® (Interferon gamma-1b) for human use.
Autor: Green DS; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA., Nunes AT; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA., Tosh KW; Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., David-Ocampo V; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.; Office of Tissues and Advanced Therapies, Center for Biologics and Evaluation and Research, FDA, Silver Spring, MD, USA., Fellowes VS; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Ren J; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Jin J; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Frodigh SE; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Pham C; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Procter J; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Tran C; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Ekwede I; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA., Khuu H; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.; Office of Tissues and Advanced Therapies, Center for Biologics and Evaluation and Research, FDA, Silver Spring, MD, USA., Stroncek DF; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Highfill SL; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Zoon KC; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Annunziata CM; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA. annunzic@mail.nih.gov.
Publikováno v: Journal of translational medicine [J Transl Med] 2019 Mar 14; Vol. 17 (1), pp. 82. Date of Electronic Publication: 2019 Mar 14.
Zobrazit plný text záznamu
10
Akademický článek
A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron ® (Peginterferon alfa-2b) and Actimmune ® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer.
Autor: Green DS; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA., Nunes AT; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA., David-Ocampo V; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, USA.; Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA., Ekwede IB; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA., Houston ND; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA., Highfill SL; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, USA., Khuu H; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, USA.; Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA., Stroncek DF; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, USA., Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zoon KC; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health Bethesda, Bethesda, MD, USA., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive RM 3B43C, Bethesda, MD, 20892, USA. annunzic@mail.nih.gov.
Publikováno v: Journal of translational medicine [J Transl Med] 2018 Jul 16; Vol. 16 (1), pp. 196. Date of Electronic Publication: 2018 Jul 16.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje